Daily market insights on Telegram
Share Predictions

Stocks

Stock predictionsToday's rankings and AI sentiment SectorsWhere each part of the market leans Stock directoryEvery U.S. stock, A to Z AI trading portfolioA simulation of the predictions Penny stocks portfolioA simulation, for penny stocks

Options

Options chainCalls and puts for any U.S. stock Options predictionsEvery closed one, wins and losses Options directoryEvery optionable stock, A to Z Options guidesFrom Greeks to spreads, in plain words

Apps

SharePredsStocks OpPredsOptions CPredsCrypto TradeSimSimulator Average CostCalculator All apps

Tools

All trading tools Get SharePreds

VistaGen Therapeutics, Inc. Common Stock (VTGN) stock analysis and AI prediction

The company facts of VistaGen Therapeutics, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.

Keep looking in SharePreds

You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.

QR code that opens SharePreds in your phone's app storeScan with your phone
See all five apps
SharePreds ranking U.S. stocks by their chance of rising over the next 10 days

About VistaGen Therapeutics, Inc. Common Stock

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Exchange
NASDAQ
Market value
$7.9 million
Employees
41
Headquarters
SOUTH SAN FRANCISCO, CA
Listed since
July 1, 2009

VTGN questions

What is the AI prediction for VTGN stock?

Each market day our model rates VistaGen Therapeutics, Inc. Common Stock (VTGN) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.

How often is the VTGN prediction updated?

Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.

What do Bullish, Neutral and Bearish mean?

Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.

Where can I see the exact likelihood for VTGN?

In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.

Where can I see VTGN options?

The VTGN options page opens its calls and puts, with price, volume, implied volatility and the Greeks.